A scientific statement from the American Heart Association was published in Circulation, with the purpose of providing a thorough review of available evidence on HIV-associated cardiovascular disease.
This article describes the populations at high risk for HIV infection and reports the results of a collaborative, multifaceted educational intervention designed to reduce the documented disparities related to HIV care and prevention.
Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination.
The risk of sudden cardiac death was present across all strata of left ventricular ejection fraction and was related to the use of cocaine, lower use of beta-blockers, lower CD4, and nonsuppressed viral load.
In the NAMSAL ANRS 12313 trial, investigators compared a dolutegravir-based regimen with a low-dose efavirenz-based regimen for the treatment of HIV-1 infection.
Human immunodeficiency virus treatment may be improved in incarcerated individuals with interdisciplinary academic medical care delivered via telemedicine.
To improve steps along the PrEP care continuum for HIV prevention, sustainable program strategies are vital in the black and Latino MSM populations in the southern United States.
Although adding ibalizumab to an optimized background regimen of ART is not cost-effective, ibalizumab substantially increased survival for individuals with multidrug-resistant HIV.
Monthly injections of long-acting formulations of cabotegravir and rilpivirine were noninferior to daily oral combination antiretroviral therapy for maintaining HIV-1 suppression and also offered improved treatment satisfaction.
Two studies investigating the safety of dolutegravir-based ART during pregnancy found that higher rates of adverse pregnancy outcomes did not occur in women who initiated treatment before conception.
Implementing an indeterminate range would support more accurate nucleic acid-based early infant diagnosis of HIV and likely reduce the number of infants put on lifelong treatment unnecessarily.
